Literature DB >> 22372227

Completion of the statement of fitness for work: concise guidance.

Simon Thornhill1, Nerys Williams.   

Abstract

Doctors are required to issue Form Med 3 (the Statements of Fitness for Work, commonly known as the fit note) where appropriate to patients for whom they provide clinical care. Much sickness absence is attributed to mild or moderate mental ill health, musculoskeletal or cardiorespiratory conditions. The effects of these conditions and others can often be accommodated at work, with appropriate adjustments, adaptations or support if necessary. Employers have a crucial role in achieving this; however, they need advice on the functional effects of the condition to do so. Evidence shows that work can be therapeutic and help promote recovery and rehabilitation. Conversely, unemployment is generally harmful to health and can lead to increased morbidity and poorer physical and mental health, as well as poverty, health inequalities and social exclusion. This concise guideline has been developed to aid doctors in understanding when and how to issue a fit note to the greatest benefit for their patients.

Entities:  

Mesh:

Year:  2012        PMID: 22372227      PMCID: PMC4953424          DOI: 10.7861/clinmedicine.12-1-63

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  1 in total

1.  Generating the evidence base for the National Service Framework for Long Term Conditions: a new research typology.

Authors:  Lynne Turner-Stokes; Richard Harding; Judith Sergeant; Carol Lupton; Kath McPherson
Journal:  Clin Med (Lond)       Date:  2006 Jan-Feb       Impact factor: 2.659

  1 in total
  1 in total

1.  Health condition at first fit note and number of fit notes: a longitudinal study of primary care records in south London.

Authors:  Sarah Dorrington; Ewan Carr; C Polling; Sharon Stevelink; Mark Ashworth; Emmert Roberts; Matthew Broadbent; Stephani Hatch; Ira Madan; Matthew Hotopf
Journal:  BMJ Open       Date:  2021-03-26       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.